Asserter profile
Sun Pharma Global FZE
operating company0 patents now2 ever1 case filed during tenure2 connections
Two-hop network
Edges marked ⚖️ overlap with at least one infringement suit filed during the receiving entity’s tenure with the patent. Bold-bordered = this entity. Red = NPE; orange = shell LLC; green = defensive aggregator; blue = operating company.
flowchart LR
Nsun_pharma_global_fze["Sun Pharma Global FZE"]
Ninsite_vision["InSite Vision Incorporated"]
Nsun_pharmaceutical["SUN PHARMACEUTICAL INDUSTRIES, INC."]
Nhosseini_kamran_bowman_lyle["Hosseini, Kamran; Bowman, Lyle"]
Nhosseini_kamran_bowman_lyle_si_erwin_c_pham_stephen["Hosseini, Kamran; Bowman, Lyle; Si, Erw…"]
Nu_s_bank_national_association_as_collateral_agent["U.S. BANK TRUST COMPANY, NATIONAL ASSOC…"]
Nqlt["QLT Inc."]
Nranbaxy["Ranbaxy, Inc."]
Nu_s_bank_national_association["U.S. BANK TRUST COMPANY, NATIONAL ASSOC…"]
Nkamran_hosseini_lyle_bowman_erwin_c_si_stephen_pham["Kamran Hosseini, Lyle Bowman, Erwin C.…"]
Ndusa_pharmaceuticals["DUSA PHARMACEUTICALS, INC."]
Ninsite_vision ==>|"⚖️ 2016 · Assignment · 8778999"| Nsun_pharma_global_fze
Nsun_pharma_global_fze ==>|"⚖️ 2022 · Merger · 8778999"| Nsun_pharmaceutical
Ninsite_vision -->|"2016 · Assignment · RE50218"| Nsun_pharma_global_fze
Nsun_pharma_global_fze ==>|"⚖️ 2021 · Merger · RE50218"| Nsun_pharmaceutical
Nhosseini_kamran_bowman_lyle -->|"2009 · Assignment · 8778999"| Ninsite_vision
Nhosseini_kamran_bowman_lyle_si_erwin_c_pham_stephen -->|"2009 · Correction · 8778999"| Ninsite_vision
Ninsite_vision -->|"2014 · Security Agreement · 8778999"| Nu_s_bank_national_association_as_collateral_agent
Nqlt -->|"2015 · Release · 8778999"| Ninsite_vision
Ninsite_vision -->|"2015 · Security Agreement · 8778999"| Nranbaxy
Nranbaxy -->|"2015 · Release · 8778999"| Ninsite_vision
Nu_s_bank_national_association -->|"2015 · Release · 8778999"| Ninsite_vision
Nkamran_hosseini_lyle_bowman_erwin_c_si_stephen_pham -->|"Assignment · RE50218"| Ninsite_vision
Ndusa_pharmaceuticals ==>|"⚖️ 2024 · Merger · 11697028"| Nsun_pharmaceutical
classDef focal fill:#fef3c7,stroke:#92400e,stroke-width:3px,color:#1c1917
classDef npe fill:#fee2e2,stroke:#be123c,stroke-width:2px,color:#1c1917
classDef shell fill:#fed7aa,stroke:#9a3412,stroke-width:2px,color:#1c1917
classDef defensive fill:#dcfce7,stroke:#15803d,stroke-width:2px,color:#1c1917
classDef operating fill:#e0f2fe,stroke:#075985,stroke-width:1px,color:#1c1917
class Nsun_pharma_global_fze focal
class Ninsite_vision operating
class Nsun_pharmaceutical operating
class Nu_s_bank_national_association_as_collateral_agent operating
class Nu_s_bank_national_association operating
class Ndusa_pharmaceuticals operating
Patents previously held (2)
- US RE502182016-03 → 2021-10-01
- US 87789992016-03-01 → 2022-03-11
- Sun Pharmaceutical Industries Ltd. et al. v. Lupin Ltd. et al. filed 2018-02-15
Connected entities (2)
- InSite Vision Incorporatedoperating company2 patents · ⚖️ 1
- SUN PHARMACEUTICAL INDUSTRIES, INC.operating company2 patents · ⚖️ 2